BriaCell Therapeutics Corp. (BCTXL)
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
BriaCell Therapeutics Corp.
No financial data available.
No debt & equity data available.
No short interest data available.
No splits on record
Nothing in BCTXL's public trading history: no forward or reverse split has affected the share count.
No balance sheet details available.
No income statement data available.
No balance sheet data available.
No cash flow data available.